Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Wall Street
Price Targets
REGN Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for REGN is 1 069.29 USD with a low forecast of 727.2 USD and a high forecast of 1 248.45 USD.
REGN Last Price Targets
Regeneron Pharmaceuticals Inc
The latest public price target was made on Apr 12, 2024 by Akash Tewari from Jefferies , who expects REGN stock to rise by 17% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Regeneron Pharmaceuticals Inc
For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's operating income is 16%. The projected CAGR for the next 3 years is 15%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is REGN's stock price target?
Price Target
1 069.29
USD
According to Wall Street analysts, the average 1-year price target for REGN is 1 069.29 USD with a low forecast of 727.2 USD and a high forecast of 1 248.45 USD.
What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 3 years is 7%.
What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
15%
For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's operating income is 16%. The projected CAGR for the next 3 years is 15%.
What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
14%
For the last 8 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's net income is 26%. The projected CAGR for the next 3 years is 14%.